Giant Biogene Holding Co Ltd (HKSE:02367) Share Price

Company Profile

Business description
Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.
Contact
No. 1855, Shanglin Yuan 7th Road
Chang’an District
Shaanxi Province
Xi’an
CHN
https://www.xajuzi.com
Sector
Consumer Defensive
Stock type
Defensive
Industry
Household & Personal Products
Fiscal Year End
31 December 2026
Employees
2,201

Recommended

The business faces long-term headwinds due to cost-of-living pressures in the US and hospital capacity constraints in Europe.

Shane Ponraj, CFA | 24 April 2026

Microsoft’s earnings report is expected to touch on AI adoption and monetization.

Dan Romanoff, CPA | 23 April 2026

The ongoing war is likely to keep commodity prices even more volatile than usual until it is resolved.

Jon Mills, CFA | 23 April 2026

Index	Last price	Change	% Change
All Ordinaries	9,024.20	27.20	-0.30%
CAC 40	8,227.32	70.89	0.87%
DAX 40	24,155.45	39.45	-0.16%
Dow JONES (US)	49,310.32	179.71	-0.36%
FTSE 100	10,457.01	19.45	-0.19%
HKSE	25,915.20	248.04	-0.95%
NASDAQ	24,438.50	219.06	-0.89%
Nikkei 225	59,140.23	445.63	-0.75%
NZX 50 Index	12,881.11	3.82	-0.03%
S&P 500	7,108.40	29.50	-0.41%
S&P/ASX 200	8,793.40	26.10	-0.30%
SSE Composite Index	4,093.25	13.01	-0.32%